fda compounding semaglutide crackdown october 2025 Despite crackdown, unapproved GLP-1s still threaten the industry The FDA announced plans to

"Intravenous administration achieves high plasma concentrations of vital nutrients that are unachievable by oral means, maximizing systemic therapeutic benefits, particularly for antioxidant compounds like Vitamin C and Glutathione."Clinical Review: Bioavailability of Intravenous Nutrient Therapy Just Wellness clinical protocols are based on current peer-reviewed nutritional research

Ozempic was already the third most prescribed drug in Canada last year with 7,390,000 prescriptions dispensed, a 17 per cent increase over 2023, according to drug analytics research firm IQVIA

No single brand universally tops the list for glutathione tablets

All documented evaluations remain confined to investigational, analytical, and preclinical research environments